# Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric Cancer

> **NCT00210184** · PHASE2 · COMPLETED · sponsor: **Institut Bergonié** · enrollment: 42 (actual)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** Irinotecan associated to fluorouracil and leucovorin

## Key facts

- **NCT ID:** NCT00210184
- **Lead sponsor:** Institut Bergonié
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07-21
- **Primary completion:** 2009-04
- **Final completion:** 2010-04
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2021-10-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00210184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00210184, "Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00210184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*